Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$409.2M
-1.2% from 2023
Prescriptions
2.6M
$157.76 per claim
Patients
780K
234,115 prescribers
Total spending, 2024
$409.3M
$524.84 per patient
Medicare prescription drug plans paid $409.2M for Fluticasone-Salmeterol in 2024, for 2,593,583 prescriptions and refills to 779,609 patients (down 1.2% from 2023). The average cost per claim was $157.76.
New York had the highest Medicare cost for Fluticasone-Salmeterol in 2024: $31.8M for 204,304 claims, followed by Florida ($30.9M).
Jorge Sanchez-Masiques, pulmonary disease in Miami, FL, had the highest Medicare cost for Fluticasone-Salmeterol in 2024: 4,171 claims costing $360K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Jorge Sanchez-Masiques Miami, FL | Pulmonary Disease | 4,171 | 786 | $360K |
| Ashesh D Desai Conroe, TX | Pulmonary Disease | 737 | 330 | $203K |
| Urvashi Bhan |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 164,228 | 1,224,333 | 379,011 | $306.3M |
| 2023 | 182,777 | 1,467,734 | 463,904 | $414.2M |
| 2024 | 234,115 | 2,593,583 | 779,609 | $409.2M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Pulmonary Disease |
| 368 |
| 168 |
| $117K |
| Celestino Pietrantoni Williamsville, NY | Pulmonary Disease | 540 | 150 | $102K |
| Sherif Sherif Williamsville, NY | Pulmonary Disease | 481 | 110 | $97K |
| Sameer T Sawalha Dearborn, MI | Internal Medicine | 304 | 69 | $96K |
| Robert A Pensler Wyandotte, MI | Pulmonary Disease | 506 | 175 | $93K |
| Jennifer Rankie Williamsville, NY | Physician Assistant | 320 | 125 | $90K |
| Thomas K Chan New York, NY | Pulmonary Disease | 820 | 123 | $88K |
| Nashat H Rabadi Buffalo, NY | Pulmonary Disease | 324 | 117 | $87K |
| Theodossis Zacharis New Smyrna Beach, FL | Pulmonary Disease | 643 | 241 | $84K |
| Reuven Moshenyat Brooklyn, NY | Pulmonary Disease | 568 | 156 | $78K |
| John H Rowlands Tacoma, WA | Pulmonary Disease | 422 | 105 | $77K |
| Mazhar Elamir Jersey City, NJ | Internal Medicine | 471 | 145 | $75K |
| Nelson N Aldana Tampa, FL | Pulmonary Disease | 1,177 | 309 | $74K |
| Craig M Rundbaken Sun City West, AZ | Pulmonary Disease | 392 | 148 | $72K |
| Modupe O Kehinde Lebanon, TN | Pulmonary Disease | 414 | 121 | $72K |
| Hossam H Amin Brooklyn, NY | Pulmonary Disease | 311 | 62 | $72K |
| Samuel A Amill-Acosta Manati, PR | Pulmonary Disease | 602 | 183 | $71K |
| Richard A Malmsten Holland, MI | Physician Assistant | 278 | 76 | $71K |
| Todd R Sudik Du Bois, PA | Nurse Practitioner | 401 | 100 | $71K |
| Samir D Shah Newton, NJ | Pulmonary Disease | 436 | 150 | $70K |
| Andres A Redondo Miami, FL | Pulmonary Disease | 695 | 158 | $70K |
| Jeffery R Neu Williamsville, NY | Pulmonary Disease | 390 | 88 | $70K |
| Ngoc An Phan Philadelphia, PA | Internal Medicine | 183 | 48 | $69K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Prasco Labs | 1,063,618 | $184.6M |
| West-Ward/Hikma HIK.L | 1,015,133 | $143.1M |
| Teva USA TEVA | 363,716 | $52.0M |
| Hikma Pharmaceu HIK.L | 152,012 | $29.6M |